GLP-1 Agonists
Sort by:
Scripps Health: 2019 Updates in Diabetes Management
Diabetes Discussion: Focus on GLP-1
FEATURING
Matthew Levine
- 494 views
- June 26, 2019
- 2
Scripps Health: 2019 Updates in Diabetes Management
Management of Hyperglycemia: Impact on Complications in the CVOT Era
FEATURING
Daniel Einhorn
- 504 views
- June 26, 2019
- 6
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almost
FEATURING
Ralph DeFronzo
- 11,626 views
- August 12, 2019
- 58
Cardiometabolic Health Congress (CMHC)
Review of Recent CVOTs Results and Clinical Implications
FEATURING
Lawrence Blonde
- 16 views
- October 22, 2019
Cardiometabolic Health Congress (CMHC)
Individualization of Treatment in T2DM Patients with CVD
FEATURING
Harold Bays
- 528 views
- October 22, 2019
- 5
Cardiometabolic Health Congress (CMHC)
CVOT Data in Your Clinical Practice: Patient Case and Audience Q&A
FEATURING
Robert Eckel
- 29 views
- October 22, 2019
Diabetes Updates
Best of EASD 2019: CVD Perspective
FEATURING
Peter Gaede
- 167 views
- October 23, 2019
Emory Diabetes Education Training Academy
Standards of Diabetes Care: Cardiovascular Disease and Risk Management
FEATURING
Guillermo Umpierrez
- 159 views
- May 15, 2020
- 1
Emory Diabetes Education Training Academy
Antihyperglycemic Medication in Type 2 Diabetes: Overall Approach
FEATURING
Guillermo Umpierrez
- 1,219 views
- May 15, 2020
- 4
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,784 views
- May 15, 2020
- 22
26th Annual San Diego Heart Failure Symposium
SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk
FEATURING
Pam Taub
- 893 views
- December 16, 2020
- 3
John Tayek
ADA Standard of Care 2020 Update: What Are the Insulin Therapy Recommendations?
- 1,072 views
- January 7, 2021
- 6
Cardiometabolic Health Congress (CMHC)
CKD & Diabetes Management: The Role of GLP-1 RAs in Kidney Protection
FEATURING
Katherine R. Tuttle
- 1,243 views
- January 15, 2021
- 7
Cardiometabolic Health Congress (CMHC)
SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Are the Beneficial Effects on Reducing CVD Events?
FEATURING
Robert Eckel
- 176 views
- January 15, 2021